icon
Treatments
Programmeicon
How it works
Treatments, coaching and habit change programme
Coaching
The support of a dedicated health coach
Voy app
Track your progress whilst creating healthy sustainable habits
Results
About
Experts
Resourcesicon
Guides & tips
Tools and tips for lasting weight loss
Research & science
Evidence-based insights and clinical research
icon
icon
menu-close
OVERVIEW
Treatments
icon
How it works
icon
Coaching
icon
Voy app
icon
EXPLORE
Results
icon
About
icon
Experts
icon
Resources
icon
ACCOUNT
Login
icon
GET IN TOUCH
020 3912 9885
Mon-Fri 9:00-17:30
icon
Guides & tips
icon
Research & science
icon
Home/Guides & Tips/Medications/

Is Wegovy safe?

Is Wegovy safe?

Wegovy can be a gamechanger for people living with obesity and most people tolerate it well. But that doesn’t mean it’s right for everyone.

clinician image

Medically reviewed by

Dr Earim Chaudry (MBBS), Chief Medical Officer

iconPublished 11th March 2025
Research-Based Guide
Table of contents
  • Is Wegovy safe for weight loss...
  • What are the health risks of u...
  • Who should avoid taking Wegovy...
  • How can you take Wegovy safely...
  • Ready to take the next step in...

You may have seen some alarming headlines about the supposed dangers of weight loss medications. So, let’s get straight to the point: Wegovy (which contains semaglutide, the same active ingredient as Ozempic) is safe for most people who are living with obesity.

And you can rest assured that the smartest, most cautious organisations in the world agree. The drug was approved by The Food and Drug Administration (FDA) in the US and the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK after rigorous clinical tests.

But Wegovy weight loss injections definitely aren’t the right fit for everyone. In fact, the drug may be dangerous for some people, depending on their medical circumstances and history. We’ll cover everything you need to know about taking Wegovy safely.

Is Wegovy safe for weight loss?

Wegovy—the brand name for semaglutide—works well for weight loss when it’s taken once a week as an injection and paired with regular exercise and a balanced diet. Semaglutide is a GLP-1 receptor agonist. It mimics a natural hormone in your gut that suppresses your appetite and regulates your blood sugar. People in clinical trials lost an average of 15% of their weight within 68 weeks (around 15 months).

Is Wegovy safe for weight loss? The risk of serious problems is low in people who Wegovy is indicated for. That’s why it’s been FDA and MHRA-approved. The drug has only been available for a few years though, so we don’t have much long-term data yet.

Remember, Wegovy is only approved—and therefore safe—for certain people and if it’s taken in the right way. It can be unsafe if:

  • You have other medical conditions, such as active cancer, problems with your gallbladder or gallstones or have had pancreatitis (inflammation of the pancreas) in the past.
  • You use it without a prescription or consulting a healthcare professional who knows your medical history.
  • You take a higher dose or use it in a different regime than your healthcare provider has prescribed, in an attempt to speed up your weight loss.
  • You get it from an unregulated website rather than from a registered pharmacy.
Discover Wegovy
Struggling to reach your target weight? You’re not alone. Find out about how medications like Wegovy can boost your efforts and get you closer to your health goals.
icon
Science backed programme
icon
Personalised support
icon
Trusted by 100,000 UK customers

What are the health risks of using Wegovy?

As with all medications, you may have some Wegovy side effects. Most are common and mild. People very rarely experience serious side effects. As they can happen, it’s important to use Wegovy alongside medical supervision. A clinician will keep an eye on any symptoms and tweak your dose if they need to.

Mild side effects

There are a few side effects that affect around one in 10 people. They tend to be mild, short-lived and manageable. They include:

  • Nausea
  • Vomiting
  • Acid reflux
  • Diarrhoea
  • Constipation
  • Changes in how food and drink tastes

You may notice these more when you first start taking Wegovy. If any side effects don’t quickly resolve and are bothering you, speak to your clinician. You can help to minimise them by following a Wegovy diet plan.

Serious risks

The research assures us that most people who are prescribed Wegovy, and take it correctly, don’t have any severe side effects. More serious Wegovy risks do exist, but they’re very rare. They include:

  • Inflammation of the pancreas (pancreatitis).
  • Gallbladder disease.
  • Low blood sugar.

There have been some scary stories in the media about Wegovy and cancer. The truth is that it has been linked to thyroid tumours in animal studies. We don’t know for sure whether the same risks exist in humans. So, to be extra safe, anyone at risk (or with a family history of) thyroid cancer will not be prescribed the drug.

If you notice any unusual symptoms while you’re using Wegovy, it’s important to let your clinician know.

Side effects support at Voy

"If you're using Voy and you experience any side effects, rest assured that our expert clinicians are just a message or phone call away. They can adjust your dose, prescribe medication to ease your symptoms, or simply offer reassurance.

Everyone responds differently to weight loss treatment and we'll help you find what feels right for you."

Phoebe Fox - Weight Loss Specialist Clinician

Who should avoid taking Wegovy?

Reminder: Wegovy is only meant for people with a BMI of 30 or higher, or a BMI of at least 27 who also have another health condition related to their weight. If you meet the criteria, a clinician needs to make the ultimate decision on whether Wegovy is safe for you to use. They’ll take your unique medical situation, history and any other medications you’re using into account.

If you’re wondering who should not take Wegovy, it isn’t safe if you’re pregnant, breastfeeding or trying to conceive.

You also shouldn’t take it if you have:

  • Active cancer
  • A family history of thyroid cancer
  • Multiple endocrine neoplasia syndrome type 2 (MEN2).
  • Liver, kidney or congestive heart failure
  • Pancreatitis
  • Diabetes-related eye problems
  • A history of eating disorders
  • A history of gallbladder problems
  • Inflammatory bowel disease (IBD)
  • Gastroparesis

How can you take Wegovy safely?

To safely use Wegovy, you should only take it if it’s been prescribed to you by a clinician. As the drug can come with side effects, it’s really important to work closely with a healthcare professional and follow their advice about safe Wegovy doses for weight loss.

Ready to take the next step in your weight loss journey?

As long as you consult a healthcare professional before starting Wegovy and take it the right way, it’s safe. If you do happen to notice any unfamiliar symptoms, check in with your clinician.

If Wegovy isn’t the right fit for you, the good news is that there are other options. Take Voy’s weight loss quiz to find out if you’re eligible for Wegovy or another one of our programmes.

Looking to start you weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
FAQ

Is Wegovy safe: FAQ

Dr Earim Chaudry, MBBS
DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
Reference
icon¹

“FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014.” The Food and Drug Administration (FDA), 4 Jun, 2021, https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014. Accessed 4 Mar. 2025.

icon²

Gao, Xueqin, et al. “Efficacy and Safety of Semaglutide on Weight Loss in Obese or Overweight Patients without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Frontiers in Pharmacologyscribble-underline, vol. 13, Frontiers Media SA, Sept. 2022, p. 935823. https://pmc.ncbi.nlm.nih.gov/articles/PMC9515581.

icon³

“Highlights of Prescribing Information.” Novo Nordisk. https://www.novo-pi.com/wegovy.pdf. Accessed 4 Mar. 2025.

icon⁴

Jensterle, Mojca, et al. “Does Intervention with GLP-1 Receptor Agonist Semaglutide Modulate Perception of Sweet Taste in Women with Obesity: Study Protocol of a Randomized, Single-Blinded, Placebo-Controlled Clinical Trial.” Trialsscribble-underline, vol. 22, no. 1, Springer Science and Business Media LLC, July 2021, p. 464. https://pmc.ncbi.nlm.nih.gov/articles/PMC8287101.

icon⁵

“MHRA Approves GLP-1 Receptor Agonist Semaglutide to Reduce Risk of Serious Heart Problems in Obese or Overweight Adults.” Healthcare Products Regulatory Agencyscribble-underline, 23 Jul, 2024, https://www.gov.uk/government/news/mhra-approves-glp-1-receptor-agonist-semaglutide-to-reduce-risk-of-serious-heart-problems-in-obese-or-overweight-adults. Accessed 4 Mar. 2025.

icon⁶

Shu, Yamin, et al. “Gastrointestinal Adverse Events Associated with Semaglutide: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System.” Frontiers in Public Healthscribble-underline, vol. 10, Frontiers Media SA, Oct. 2022, p. 996179. https://pmc.ncbi.nlm.nih.gov/articles/PMC9631444.

icon⁷

Smits, Mark M., and Daniël H. Van Raalte. “Safety of Semaglutide.” Frontiers in Endocrinologyscribble-underline, vol. 12, 2021, article 645563. pmc.ncbi.nlm.nih.gov/articles/PMC8294388/.

icon⁸

Wegovy. “Package Leaflet: Information for the Patient.” Electronic Medicines Compendiumscribble-underline, www.medicines.org.uk/emc/files/pil.13800.pdf. Accessed 11 Dec. 2024.

icon⁹

Wharton, Sean, et al. “Gastrointestinal Tolerability of Once-Weekly Semaglutide 2.4 mg in Adults with Overweight and Obesity, and the Relationship Between Gastrointestinal Adverse Events and Weight Loss.” Diabetes, Obesity and Metabolismscribble-underline, vol. 24, no. 1, 2021, pp. 94–105. pmc.ncbi.nlm.nih.gov/articles/PMC9293236/.

icon¹⁰

Wilding, John P. H., et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” The New England Journal of Medicinescribble-underline, vol. 384, no. 11, Massachusetts Medical Society, Mar. 2021, pp. 989–1002. https://pubmed.ncbi.nlm.nih.gov/33567185/.

card-image
Medication
How long does it take for Mounjaro to suppress appetite?
Taking Mounjaro and still craving comfort foods? Here’s what might be going on.
card-image
Medication
What is Ozempic mouth?
Here we take a look at what’s being dubbed “Ozempic mouth” and whether it’s something you need to worry about.
card-image
Medication
Retatrutide, tirzepatide, or semaglutide?
Wondering how different weight loss medicines stack up? Here’s a head-to-head comparison of retatrutide vs tirzepatide vs semaglutide.
card-image
Medication
Retatrutide dosage guide
Retatrutide, a weekly weight loss injection, isn’t approved yet, but here’s what we know right now about the dosing schedule for this experimental treatment.
Have a question?
Whatever it is, get in touch:
message
020 3912 9885Mon-Fri 9:00-17:00
message
help@joinvoy.comWe aim to reply in 24hrs
Mon-Fri 9:00-17:00
We aim to reply in 24hrs
Our services are not intended for use in a medical emergency. If you need urgent medical attention, please call 111 or 999

PROGRAMME

  • How it works
  • Treatments
  • Coaching
  • The Voy app

VOY

  • Results
  • About
  • Our medical experts

HELP

  • Help Centre (FAQ)
logo
Privacy PolicyTerms & Conditions
Terms of SaleComplaints
Pharmacies: Manual Pharmacy
Superintendent Pharmacist
Vinisha Kanda
GPhC Registration: 2203475
Copyright 2025 Voy™. All rights reserved.
cards
pharmacy-contact
Privacy Preference Center
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below. The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.
Manage Consent Preferences
icon
Necessary Cookies
Always Active
Necessary cookies ensure the basic functionalities of the website, such as security, network management, and accessibility. These cookies cannot be disabled and do not store personal information.
icon
Preferences Cookies
Preferences cookies allow the website to remember information that changes the way the site behaves or looks, such as your preferred language or region.
icon
Statistics Cookies
Statistics cookies help us understand how visitors interact with the website by collecting and reporting information anonymously. These cookies provide insights into metrics such as page visits and traffic sources.
icon
Marketing Cookies
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and more valuable to publishers and third-party advertisers.